October 7th, 2015 by Charlie Blackburn | NAACCReview Home Leave a comment

Rebecca Cassady, RHIA, CTR, Director, Desert Sierra Cancer Surveillance Program (NAACCR Committee Member)

This article regarding the increase of contralateral prophylactic mastectomies (CPM) in male breast cancer patients is significant as it may change the clinical practice for male breast cancer patients. Male breast cancers represent 1% of the breast cancer incidence in relation to all breast cancers. They are usually diagnosed at a later stage which can affect survival. Men considering CPM procedures will need to have the additional discussions with their provider, surgeons, support personnel, financial counselors and family members. It is important to provide all aspects of clinical care for male breast cancer patients to ensure the best outcome of their diagnosis and good quality of life.

Read Full Article (The abstract below is an article originally posted on the JAMA Network)


This study examines the temporal trends in and the factors associated with contralateral prophylactic mastectomy among men who received a diagnosis of unilateral invasive breast cancer.

Previous studies have reported marked increases in the rates of contralateral prophylactic mastectomy (CPM) among US women who received a diagnosis of unilateral invasive breast cancer, and this increase is particularly evident among younger women. Rates of CPM among women vary depending on the population studied, although national statistics show that the percentage of women with unilateral invasive breast cancer undergoing a CPM increased from approximately 2.2% in 1998 to 11% in 2011. This increase has occurred despite the lack of evidence for a survival benefit from bilateral surgery, in addition to the complications and associated costs described in Lostumbo et al. Factors that are thought to contribute to the increase in the rate of CPM include increased testing for BRCA1/2 mutations, magnetic resonance imaging, and reconstruction surgery for symmetry, among others. However, whether the CPM rate is also increasing among US men is unknown. Herein, we used a nationwide population-based cancer database, the North American Association of Central Cancer Registries, to examine the temporal trends in and the factors associated with CPM among men who received a diagnosis of unilateral invasive breast cancer.

The opinions expressed in this article are those of the authors and may not represent the official positions of NAACCR.

Copyright © 2018 NAACCR, Inc. All Rights Reserved | naaccr-swoosh-only See NAACCR Partners and Sponsors